Andere talen Jiangsu Yahong Meditech Co., Ltd.

Aandelen

688176

CNE100005XW0

slotkoers Shanghai S.E. Andere beurzen 00:00:00 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,43 ^CNY	-4,60%		-2,87%	-40,35%

29/04	Jiangsu Yahong Meditech Co, Ltd. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
19/03	Asieris Pharmaceuticals kondigt positieve resultaten aan van multicenter fase III wereldwijde klinische studie	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Jiangsu Yahong Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Tranche Update on Jiangsu Yahong Meditech Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	02/04
Asieris Pharmaceuticals Announces Release of Positive Results from Multicenter Phase III Global Clinical Study	19/03
Jiangsu Yahong Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Asieris Pharmaceuticals to Unveil First-Ever Results of the International Multicenter Phase III Clinical Study for 1702, a Non-Surgical Treatment for Cervical HSIL, at the 2024 EUROGIN	22/02
Jiangsu Yahong Meditech to Buy Back Shares for Up to 100 Million Yuan	12/02
Jiangsu Yahong Meditech Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	07/02
Jiangsu Yahong Meditech Co., Ltd. authorizes a Buyback Plan.	06/02
Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, A Bladder Cancer Diagnosis and Management Drug, At the 2024 ASCO-GU	29/01
Asieris Pharmaceuticals Announces Set-Up of the Women's Health Business Unit for Commercialization	09/01
Asieris Pharmaceuticals Appoints Sophia Cao as Senior Vice President and Head of the Women's Health Business Unit	09/01
Certain A Shares of Jiangsu Yahong Meditech Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-JAN-2024.	07/01
Jiangsu Yahong Meditech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Asieris Pharmaceuticals Unveils Results of Its Hexvix[®] (Apl-1706) Phase III Clinical Trial in China	12-10-23
Photocure Partner Asieris Pharmaceuticals to Present First Results for its Hexvix Phase III Clinical Trial in China at the SIU2023 Annual Meeting	07-10-23
Jiangsu Yahong Meditech Completes Phase III Trial Into APL1702 Drug; Shares Drop 4%	21-09-23
Asieris Pharmaceuticals Announces the First Non-Vaccine Investigational Product for Cervical HSIL Has Achieved Its Primary Endpoint	20-09-23
Jiangsu Yahong Meditech Co., Ltd.(XSSC:688176) added to S&P Global BMI Index	18-09-23
Jiangsu Yahong Meditech Enrolls First Subjects for Ulcerative Colitis Drug Trial	15-09-23
Jiangsu Yahong Meditech Gets Nod to Trial Ulcerative Colitis Drug	30-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Jiangsu Yahong Meditech Co., Ltd.

Aandelen

688176

CNE100005XW0

Andere talen

Filters